Scott William Lowe - Genetic Mutations

Author Information

Scott William Lowe is a prominent researcher in the field of cancer biology and genetics. He is affiliated with the Cancer Biology and Genetics Program at Memorial Sloan Kettering Cancer Center, located in New York, NY, USA. His research is highly influential and focuses on understanding the molecular mechanisms of cancer and developing new therapeutic strategies.

Research Contributions

Scott William Lowe has made significant contributions to the understanding of cancer biology. In 2022 alone, he has published numerous papers on various aspects of cancer research, including antitumor effects, systemic toxicities, epigenetic reprogramming, metabolic imaging, and clinical trials of new cancer therapies. His work has provided critical insights into the mechanisms of cancer progression and resistance, as well as potential therapeutic targets. Some of his notable papers in 2022 cover topics such as the role of KMT2C deficiency in lung cancer metastasis, T cell dysfunction in cancer evasion, and the impact of senescence induction on chemo- and immunotherapy responses in ovarian cancer.

Aliases

Scott William Lowe is also known by several aliases, including Scott Lowe, Scott W. Lowe, S. W. Lowe, Scott W Lowe, Scott. W. Lowe, S W Lowe, Scot W Lowe, and S Lowe. These variations of his name can be found in different publications and databases.

Publication and Citation Metrics

Metric Value
Citation Count 95,260
H-Index 140
Paper Count 542

Publications:

Partnered Content Networks

Relevant Topics